Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists discover new regulating mechanism in cells

09.05.2006
Researchers here have discovered a new mechanism used by cells – and manipulated by retroviruses – to control the making of certain essential proteins, including some involved in cancer.

The mechanism uses an enzyme called RNA helicase A (RHA), which is made by the cell.

The study by researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the OSU College of Veterinary Medicine appears online May 7 in the journal Nature Structural and Molecular Biology.

“Our findings provide important insights into how cells regulate certain growth-proteins, many of which play an important role in cancer, and how viruses use cell mechanisms to establish an infection,” says principal investigator Kathleen Boris-Lawrie, professor of veterinary biosciences and a researcher with the OSU Comprehensive Cancer Center .

The study shows, for example, that when RHA is knocked out, the spleen necrosis virus, a retrovirus Boris-Lawrie and her collaborators were studying as a vector for gene therapy, was unable to make certain proteins. Thus, RHA might be a cellular target for future antiretroviral drugs. (Current antiretroviral drugs target the virus itself, which often becomes resistant to them, rendering the drugs ineffective. Antiretroviral drugs that affect cellular targets might be less prone to resistance.)

“Retroviruses seem to take advantage of RHA to enhance production of their own proteins, and cells use it to control the amount of particular proteins they make, many of which are involved in growth control,” says Boris-Lawrie.

“The cell has to keep tight control of these proteins to be sure they are not made at the wrong time.”

Cells use a four-step process to make most proteins. First, the cell makes a copy of a gene. The copy is called messenger RNA, or mRNA, and it describes the structure of the needed protein. Next, the mRNA is processed to remove non-essential information. Then, the message travels from the cell nucleus to another location, the cell cytoplasm. Last, other cell machinery translates the message and assembles the protein.

The findings by Boris-Lawrie and her collaborators show that RHA can play an important role in determining whether the last step of this process – translating the message and making the protein – actually happens.

For this study, the researchers first used mass spectroscopy to identify the cell protein and learned that the protein was RHA.

Then the researchers knocked out the RHA protein and learned that the retrovirus stopped making several vital proteins.

“That suggests that the retrovirus needs RHA to make these essential proteins,” says Boris-Lawrie, “and that means RHA is a potential target for antiretroviral therapy.”

The researchers also learned that when RHA is knocked out, cells can no longer make a protein called junD (pronounced “june D). The regulation of junD is lost in many cancers.

The researchers examined junD because it has something important in common with the retroviral proteins. The mRNA in both cases does not pass through the processing step of the four-step protein-making process. Normally, that processing step also adds a signal to the mRNA that facilitates the final making of the protein.

Because mRNAs like those for junD and the retrovirus are not processed, and therefore lack that signal, scientists have not understood how these mRNAs are translated into protein.

Boris-Lawrie’s findings help solve that long-standing puzzle. RHA provides the missing signal. It attaches to these mRNAs and allows them to be translated into protein. If RHA is missing, the proteins are not made.

During this study, Boris-Lawrie and her colleagues identified additional genes in the human genome that do not undergo the processing step and probably need RHA to be translated. Many of these genes encode proteins that help regulate cell growth and are involved in cancer.

Funding from the National Cancer Institute supported this research.

Darrell E. Ward | EurekAlert!
Further information:
http://www.osumc.edu

More articles from Life Sciences:

nachricht The birth of a new protein
20.10.2017 | University of Arizona

nachricht Building New Moss Factories
20.10.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>